IFNG and acute myeloid leukemia: Indeed, Tregs expanding in the peripheral blood of AML patients mediate immunosuppressive effects through IL-10 secretion, blocking IFN-γ and IL-2 production and effector T cells proliferation, potentially contributing leukemia immune escape [114].